To further explore the potency of these KC-specific nanobodies, mice with NASH were also injected with anti-Clec4F and anti-Vsig4 and imaged with SPECT/CT [151,157]. This evidence concerns the gene VSIG4 and metabolic dysfunction-associated steatohepatitis.